04/25/2024
4:24 PM | Blueprint Medicines (Filer)
| Form DEF 14A | |
04/25/2024
4:25 PM | Blueprint Medicines (Filer)
| Form ARS | |
04/25/2024
7:30 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
11:58 AM | Blueprint Medicines (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
| Form SC 13G/A | |
03/28/2024
4:57 PM | Blueprint Medicines (Subject)
Landsittel Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/26/2024
8:11 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
4:50 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/15/2024
4:22 PM | Blueprint Medicines (Subject)
Landsittel Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
3:46 PM | Blueprint Medicines (Subject)
Hurley Ariel (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
3:47 PM | Blueprint Medicines (Issuer)
Lee Philina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:17 PM | Blueprint Medicines (Subject)
Lee Philina (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
5:24 PM | Blueprint Medicines (Issuer)
Murray Christopher K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:26 PM | Blueprint Medicines (Issuer)
Lee Philina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:27 PM | Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:28 PM | Blueprint Medicines (Issuer)
Durso-Bumpus Debra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:29 PM | Blueprint Medicines (Issuer)
Hewes L. Becker (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:15 PM | Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:18 PM | Blueprint Medicines (Issuer)
McCain Tracey L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:19 PM | Blueprint Medicines (Issuer)
Carter Percy H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:20 PM | Blueprint Medicines (Issuer)
Namouni Fouad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:21 PM | Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:23 PM | Blueprint Medicines (Issuer)
Landsittel Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:22 PM | Blueprint Medicines (Issuer)
Lee Philina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:15 PM | Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:16 PM | Blueprint Medicines (Issuer)
Carter Percy H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:17 PM | Blueprint Medicines (Issuer)
Landsittel Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:18 PM | Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:19 PM | Blueprint Medicines (Issuer)
Hewes L. Becker (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:20 PM | Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:20 PM | Blueprint Medicines (Issuer)
Durso-Bumpus Debra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:21 PM | Blueprint Medicines (Issuer)
Namouni Fouad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
9:41 AM | Blueprint Medicines (Issuer)
Murray Christopher K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:19 PM | Blueprint Medicines (Subject)
Murray Christopher K. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
2:06 PM | Blueprint Medicines (Issuer)
Murray Christopher K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
3:03 PM | Blueprint Medicines (Subject)
Murray Christopher K. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/22/2024
7:20 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
3:40 PM | Blueprint Medicines (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/15/2024
4:26 PM | Blueprint Medicines (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/15/2024
6:05 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
5:54 PM | Blueprint Medicines (Issuer)
Lee Philina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
7:35 AM | Blueprint Medicines (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad) If you think AI is big, then you have got to check out something I call Imperium…
By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.) Watch my video for all of the details |
01/29/2024
5:13 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
8:46 AM | BlackRock Inc. (Filed by)
Blueprint Medicines (Subject)
| Form SC 13G/A | |
01/10/2024
9:16 AM | Blueprint Medicines (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
01/08/2024
7:03 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2023
3:24 PM | Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
2:56 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
5:09 PM | Blueprint Medicines (Subject)
Murray Christopher K. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023
7:45 PM | Blueprint Medicines (Issuer)
Murray Christopher K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/24/2023
12:17 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2023
8:02 AM | Blueprint Medicines (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
10/30/2023
1:01 PM | Blueprint Medicines (Issuer)
Murray Christopher K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/26/2023
6:00 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/05/2023
9:47 AM | Blueprint Medicines (Issuer)
Namouni Fouad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/29/2023
1:36 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2023
5:23 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
7:15 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/24/2023
3:21 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/02/2023
3:02 PM | Blueprint Medicines (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/02/2023
6:00 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2023
5:03 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2023
6:00 PM | Beckman Daniella (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
6:02 PM | Blueprint Medicines (Issuer)
Lydon Nicholas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
6:03 PM | Blueprint Medicines (Issuer)
Borisy Alexis (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
6:04 PM | Blueprint Medicines (Issuer)
COATS LONNEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
6:04 PM | Blueprint Medicines (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
6:05 PM | Blueprint Medicines (Issuer)
Tsai John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
6:06 PM | Blueprint Medicines (Issuer)
Seely Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
6:06 PM | Blueprint Medicines (Issuer)
Goldberg Mark Alan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
6:07 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
6:52 PM | Blueprint Medicines (Issuer)
Carter Percy H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
6:48 PM | Blueprint Medicines (Issuer)
Hewes L. Becker (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
3:53 PM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/04/2023
6:18 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2023
4:30 PM | Blueprint Medicines (Filer)
| Form DEF 14A | |
04/28/2023
4:30 PM | Blueprint Medicines (Filer)
| Form DEFA14A | |
